Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Salmon calcitonin agent |
Is a |
False |
Salcatonin |
Inferred relationship |
Some |
|
Allergy to salmon calcitonin |
Causative agent |
False |
Salcatonin |
Inferred relationship |
Some |
|
Product containing salmon calcitonin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salcatonin |
Inferred relationship |
Some |
|
salcatonin 50 IE/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salcatonin |
Inferred relationship |
Some |
|
salcatonin 100 IE/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salcatonin |
Inferred relationship |
Some |
|
salcatonin 200 IE/ml injektionsvæske, opløsning, hætteglas a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salcatonin |
Inferred relationship |
Some |
|
Salcatonin 200iu nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salcatonin |
Inferred relationship |
Some |
|
laksecalcitonin 200 IE/ml næsespray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salcatonin |
Inferred relationship |
Some |
|